Section of Advanced Heart Failure and Cardiac Transplant, Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, 11-171 South Tower, Philadelphia, PA, 19104, USA.
Heart and Vascular Clinic, Tbilisi, Republic of Georgia.
ESC Heart Fail. 2022 Jun;9(3):1677-1681. doi: 10.1002/ehf2.13882. Epub 2022 Mar 16.
Synchronized diaphragmatic stimulation (SDS) is a novel extra-cardiac device-based therapy for symptomatic heart failure with reduced ejection fraction. SDS provides imperceptible chronic stimulation of the diaphragm through a laparoscopically implanted system consisting of an implantable pulse generator and two sensing/stimulating leads affixed to the inferior surface of the diaphragm delivering imperceptible R-wave gaited pulses that alter intrathoracic pressure improving ventricular filling and cardiac output. We describe, in a man with a history of myocardial infarctions resulting in heart failure and persistent New York Heart Association Class III symptoms despite standard therapies, the successful implantation of SDS resulting in improved quality of life, N-terminal pro brain natriuretic peptide, cardiac function, and exercise tolerance through 12 months of follow-up. Randomized trials are now required to validate these findings.
同步膈肌刺激(SDS)是一种新型的基于心脏外设备的治疗方法,适用于射血分数降低的有症状心力衰竭。SDS 通过一个腹腔镜植入系统提供对膈肌的不可察觉的慢性刺激,该系统由一个可植入脉冲发生器和两个固定在膈肌下表面的感应/刺激导线组成,可传递不可察觉的 R 波引导脉冲,改变胸内压力,改善心室充盈和心输出量。我们描述了一位男性患者的病例,他有心肌梗死病史,导致心力衰竭,尽管接受了标准治疗,但仍持续存在纽约心脏协会 III 级症状。通过 12 个月的随访,SDS 的成功植入改善了患者的生活质量、N 端脑利钠肽前体、心功能和运动耐量。现在需要进行随机试验来验证这些发现。